Chemoinformaics analysis of P-METHOXYBENZOIC-ACID
| Molecular Weight | 362.554 | nRot | 16 |
| Heavy Atom Molecular Weight | 324.25 | nRig | 7 |
| Exact Molecular Weight | 362.282 | nRing | 1 |
| Solubility: LogS | -6.978 | nHRing | 0 |
| Solubility: LogP | 8.438 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 66.1541 |
| nHD | 0 | BPOL | 42.4619 |
| QED | 0.236 |
| Synth | 1.801 |
| Natural Product Likeliness | -0.09 |
| NR-PPAR-gamma | 0.026 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.761 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.896 |
| MDCK | 0.0000152 |
| BBB | 0.049 |
| PPB | 0.986023 |
| VDSS | 3.015 |
| FU | 0.011634 |
| CYP1A2-inh | 0.208 |
| CYP1A2-sub | 0.204 |
| CYP2c19-inh | 0.452 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.128 |
| CYP2c9-sub | 0.951 |
| CYP2d6-inh | 0.475 |
| CYP2d6-sub | 0.385 |
| CYP3a4-inh | 0.406 |
| CYP3a4-sub | 0.076 |
| CL | 6.4 |
| T12 | 0.095 |
| hERG | 0.543 |
| Ames | 0.005 |
| ROA | 0.007 |
| SkinSen | 0.963 |
| Carcinogencity | 0.046 |
| EI | 0.984 |
| Respiratory | 0.437 |
| NR-Aromatase | 0.292 |
| Antiviral | Yes |
| Prediction | 0.639015 |